Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:46 pm Purchase | 13G | NEUBASE THERAPEUTICS INC N NBSE | GREENLIGHT CAPITAL INC | 136,350 3.700% | 136,350 (New Position) | View |
| 2023-09-20 5:28 pm Sale | 13D | NEUBASE THERAPEUTICS INC N NBSE | Symetryx Corp | 109,508 3.500% | -363,418 (-76.84%) | View |
| 2023-09-14 06:03 am Purchase | 13D | NEUBASE THERAPEUTICS INC N NBSE | Symetryx Corp | 472,926 9.100% | 44,482 (+10.38%) | View |
| 2023-08-31 11:50 am Purchase | 13D | NEUBASE THERAPEUTICS INC N NBSE | Symetryx Corp | 428,444 13.800% | 428,444 (New Position) | View |
| 2023-01-27 12:49 pm Purchase | 13G | NEUBASE THERAPEUTICS INC N NBSE | Kershner Trading Americas LLC | 1,497,226 4.460% | 1,497,226 (New Position) | View |
| 2022-02-14 3:32 pm Purchase | 13G | NEUBASE THERAPEUTICS INC N NBSE | GREENLIGHT CAPITAL INC | 2,727,027 8.300% | 700,000 (+34.53%) | View |
| 2021-02-16 3:40 pm Purchase | 13G | NEUBASE THERAPEUTICS INC N NBSE | GREENLIGHT CAPITAL INC | 2,027,027 8.700% | 488,565 (+31.76%) | View |
| 2020-12-29 12:14 pm Unchanged | 13G | NEUBASE THERAPEUTICS INC N NBSE | Kershner Trading Americas LLC | 1,339,000 1.000% | 0 (Unchanged) | View |
| 2020-05-01 4:17 pm Purchase | 13G | NEUBASE THERAPEUTICS INC N NBSE | HIRSCHMAN ORIN | 563,972 2.440% | 563,972 (New Position) | View |